| Date Filed | Type | Description |
| 07/10/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 06/09/2023 |
4
| Barat Stephen (Senior VP of Therapeutics) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Sold 888 shares
@ $0.8, valued at
$710.4 |
|
| 06/08/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/24/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/16/2023 |
8-K
| Other Events Interactive Data |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results |
| 04/25/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2023 |
SC 13G/A
| Samjo Capital LLC reports a 0% stake in HTG Molecular Diagnostics, Inc. |
| 02/03/2023 |
8-K
| Quarterly results |
| 02/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/06/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 12/29/2022 |
8-K
| Other Events Interactive Data |
| 12/22/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/21/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 12/20/2022 |
8-K
| Quarterly results |
| 12/13/2022 |
4
| Lawson Byron (SVP/Chief Commercial Officer) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/13/2022 |
4
| Lubniewski John L (President & CEO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/13/2022 |
4
| McMeans Shaun D (SVP, Finance & Admin. & CFO) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/13/2022 |
4
| Godlewski Laura Lee (SVP Finance & Administration) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 1,000 shares
@ $0.425, valued at
$425 |
|
| 12/07/2022 |
SC 13D/A
| BitNile Holdings, Inc. reports a 4.2% stake in HTG Molecular Diagnostics, Inc. |
| 12/06/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 12/02/2022 |
SC 13D/A
| BitNile Holdings, Inc. reports a 7.2% stake in HTG Molecular Diagnostics, Inc. |
| 11/30/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 11/17/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/31/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/21/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 10/21/2022 |
8-K
| Quarterly results |
| 09/30/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 09/16/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 09/15/2022 |
4
| KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $0.86, valued at
$3.4k
|
|
|